SCHEMBL27080703

SCHEMBL27080703

O=C1CCC(CN(CCN2Cc3cc(Br)ccc3C2=O)C(=O)O)N1

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PRMT5 O14744 3/20 0.35
▸ WDR77 Q9BQA1 3/20 0.35
▸ KDM4E B2RXH2 1/20 0.34
▸ ALOX15 P16050 1/20 0.34
▸ TSHR P16473 1/20 0.34
▸ SIRT1 Q96EB6 1/20 0.34
▸ CRBN Q96SW2 4/20 0.33
▸ KCNA5 P22460 4/20 0.33
▸ DDB1 Q16531 1/20 0.33
▸ SDCBP O00560 1/20 0.33
▸ SDC2 P34741 1/20 0.33
▸ CSNK1A1 P48729 4/20 0.33
▸ IKZF2 Q9UKS7 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC4 P56524 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC7 Q8WUI4 1/20 0.32
▸ HDAC8 Q9BY41 1/20 0.32
▸ HDAC9 Q9UKV0 1/20 0.32
▸ HDAC5 Q9UQL6 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27080877 1.00 PRMT5 (0.35) PRMT5WDR77KDM4EALOX15TSHR
SCHEMBL29984097 0.87 PRMT5 (0.32) PRMT5WDR77CRBNDDB1SDCBP
SCHEMBL27081925 0.87 PRMT5 (0.32) PRMT5WDR77CRBNDDB1SDCBP
SCHEMBL27080713 0.82 ROCK1 (0.33) PRMT5WDR77CRBNCSNK1A1
SCHEMBL27080095 0.82 ROCK1 (0.33) PRMT5WDR77CRBNCSNK1A1
SCHEMBL23725965 0.81 CD274 (0.36) KCNA5
SCHEMBL27080414 0.81 CD274 (0.36) KCNA5
SCHEMBL27080699 0.77 CD274 (0.37) PRMT5WDR77CRBNDDB1
SCHEMBL27080704 0.77 CD274 (0.37) PRMT5WDR77CRBNDDB1
SCHEMBL27080770 0.76 PRF1 (0.34) PRMT5WDR77CRBNDDB1SDCBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4313968-A2 SUBSTITUTED 1-ARYL-1'-HETEROARYL COMPOUNDS, SUBSTITUTED 1,1'-BIHETEROARYL COMPOUNDS, AND METHODS USING SAME Arbutus Biopharma Corporation (CA) 2024-02-07 — — EP disclosed
Send feedback